Association with proteasome determines pathogenic threshold of polyglutamine expansion diseases
- 25 December 2020
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 536, 95-99
- https://doi.org/10.1016/j.bbrc.2020.12.065
Abstract
No abstract availableKeywords
Funding Information
- Russian Science Foundation (19-15-00184)
- National Institutes of Health (R01NS056224)
This publication has 57 references indexed in Scilit:
- Beta conformation of polyglutamine track revealed by a crystal structure of Huntingtin N-terminal region with insertion of three histidine residuesPrion, 2013
- The proteasomal subunit Rpn6 is a molecular clamp holding the core and regulatory subcomplexes togetherProceedings of the National Academy of Sciences of the United States of America, 2011
- Polyglutamine Diseases: Where does Toxicity Come from? What is Toxicity? Where are We Going?Journal of Molecular Cell Biology, 2010
- Secondary Structure of Huntingtin Amino-Terminal RegionStructure, 2009
- Calcium signaling and neurodegenerative diseasesTrends in Molecular Medicine, 2009
- Transcriptional signatures in Huntington's diseaseProgress in Neurobiology, 2007
- Mapping and cloning of the critical region for the spinocerebellar ataxia type 1 gene (SCA1) in a yeast artificial chromosome contig spanning 1.2 MbGenomics, 1993
- Purification and characterization of a protein inhibitor of the 20S proteasome (macropain)Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992
- The primary structures of four subunits of the human, high-molecular-weight proteinase, macropain (proteasome), are distinct but homologousBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- The characterization of amino acid sequences in proteins by statistical methodsJournal of Theoretical Biology, 1968